US HB6284 | 2015-2016 | 114th Congress
Status
Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on September 28 2016 - 25% progression, died in committee
Action: 2016-09-28 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 28 2016 - 25% progression, died in committee
Action: 2016-09-28 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
EPI Act Eliminate Price Increases Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the manufacturer of a brand name drug from authorizing or commencing the manufacturing, marketing, selling, or distributing of a generic version of the drug from the time the manufacturer is notified by a generic manufacturer that a generic drug application has been submitted until the expiration or forfeiture of the 180-day exclusivity period granted to the generic manufacturer.
Title
EPI Act Eliminate Price Increases Act of 2016
Sponsors
| Rep. Adam Smith [D-WA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2016-09-28 | House | Referred to the House Committee on Energy and Commerce. |
| 2016-09-28 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-bill/6284/all-info |
| Text | https://www.congress.gov/114/bills/hr6284/BILLS-114hr6284ih.pdf |
